Graft Versus Host Disease News and Research

Latest Graft Versus Host Disease News and Research

Experimental gene therapy may improve health outcomes for patients with some forms of blood disorders

Experimental gene therapy may improve health outcomes for patients with some forms of blood disorders

Researchers discover drug target and genetic pathway for graft-versus-host disease

Researchers discover drug target and genetic pathway for graft-versus-host disease

Six-month markers predict long-term cGVHD outcomes

Six-month markers predict long-term cGVHD outcomes

Half-matched donor bone marrow transplant just as good as full match, new study shows

Half-matched donor bone marrow transplant just as good as full match, new study shows

HLA-DPB1 regulatory region genotype predicts acute GVHD

HLA-DPB1 regulatory region genotype predicts acute GVHD

Centenary Institute develops new therapeutic approach to prevent GVHD in blood cancer patients

Centenary Institute develops new therapeutic approach to prevent GVHD in blood cancer patients

HCT not precluded by prior second-generation TKI therapy in chronic, advanced phase CML

HCT not precluded by prior second-generation TKI therapy in chronic, advanced phase CML

HCT not precluded by prior second-generation TKI therapy in chronic, advanced phase CML

HCT not precluded by prior second-generation TKI therapy in chronic, advanced phase CML

Mallinckrodt subsidiary to acquire Therakos for $1.325 billion

Mallinckrodt subsidiary to acquire Therakos for $1.325 billion

New drug cures malaria in mice

New drug cures malaria in mice

Massey researchers aim to develop models that can predict complications from stem cell transplantation

Massey researchers aim to develop models that can predict complications from stem cell transplantation

Pharmacyclics’ Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

Pharmacyclics’ Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

Skin Cancer Awareness Recommended For HCT Recipients

Skin Cancer Awareness Recommended For HCT Recipients

Chemical drug safely controls side effects associated with haploidentical stem cell transplantation

Chemical drug safely controls side effects associated with haploidentical stem cell transplantation

Clinical trial uses personalized cellular therapy to treat GVHD complication of bone marrow transplant

Clinical trial uses personalized cellular therapy to treat GVHD complication of bone marrow transplant

Transplantation conditioning choices impact on CML outcomes revealed

Transplantation conditioning choices impact on CML outcomes revealed

CAR T-cell therapy enters into Phase I clinical trial

CAR T-cell therapy enters into Phase I clinical trial

Using HIV drugs to treat AMD: an interview with Dr Mark Young

Using HIV drugs to treat AMD: an interview with Dr Mark Young

Apheresis: A potent therapeutic in extracorporeal photopherisis

Apheresis: A potent therapeutic in extracorporeal photopherisis

Kiadis Pharma reports positive interim data from ATIR Phase II clinical study

Kiadis Pharma reports positive interim data from ATIR Phase II clinical study